Physician profile
Ellen Vitievsky
NPI 1366547135
$10,340.87
in general payments reported to CMS, 2019-2025
44 companies · $837 in 2025
The $837 reported for 2025 was more than what 82% of Internal Medicine providers received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,104 · 2020: $2,119 · 2021: $1,793 · 2022: $1,461 · 2023: $1,123 · 2024: $904 · 2025: $837.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,822 · Education: $42.50.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,821.63 |
| Education | $42.50 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $1,394.97 | 2019-2024 | Trulance, Xifaxan |
| Amgen INC. | $970.01 | 2019-2025 | Repatha, Otezla, Repatha |
| Glaxosmithkline, LLC. | $860.78 | 2019-2025 | Trelegy Ellipta |
| Astrazeneca Pharmaceuticals LP | $860.45 | 2019-2025 | Breztri, Farxiga, Airsupra |
| Novo Nordisk INC | $719.57 | 2019-2025 | Ozempic, Rybelsus |
| Abbvie INC. | $618.72 | 2019-2025 | Linzess, Viberzi, Creon |
| Sunovion Pharmaceuticals INC. | $538.27 | 2019-2022 | |
| Takeda Pharmaceuticals U.S.A., INC. | $506.85 | 2019-2025 | Trintellix, Gattex |
| Mylan Specialty L.P. | $400.49 | 2019-2024 | Yupelri |
| Scilex Pharmaceuticals INC. | $363.46 | 2019-2025 | Ztlido |
| Ironwood Pharmaceuticals, INC | $359.50 | 2019-2024 | Linzess |
| Amarin Pharma, INC. | $352.78 | 2019-2023 | |
| Pfizer INC. | $299.48 | 2019-2023 | |
| Sanofi-Aventis U.S. LLC | $278.09 | 2019-2022 | |
| Allergan, INC. | $223.23 | 2019-2020 |
Show all 44 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Kowa Pharmaceuticals America, INC. | $172.43 | 2020-2025 | Zoryve, Livalo, Seglentis |
| Lilly USA, LLC | $170.97 | 2019-2025 | Jardiance, Mounjaro |
| Esperion Therapeutics, INC. | $128.76 | 2020-2025 | Nexletol |
| Ardelyx, INC. | $122.99 | 2023-2025 | Ibsrela |
| Novartis Pharmaceuticals Corporation | $115.33 | 2019-2024 | |
| Horizon Therapeutics Plc | $91.17 | 2020-2022 | |
| Xeris Pharmaceuticals, INC. | $88.76 | 2023-2025 | Gvoke Hypopen |
| Mannkind Corporation | $72.11 | 2020-2025 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $69.59 | 2021-2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $69.52 | 2022-2025 | |
| Azurity Pharmaceuticals, INC. | $61.30 | 2023-2024 | Edarbyclor, Edarbi, Horizant |
| Verona Pharma, INC. | $41.68 | 2025 | Ohtuvayre |
| Merck Sharp & Dohme LLC | $41.19 | 2019-2023 | Verquvo |
| Axsome Therapeutics, INC. | $35.78 | 2022-2023 | Auvelity |
| Biohaven Pharmaceuticals, INC. | $31.90 | 2021 | |
| Nestle Healthcare Nutrition INC. | $30.28 | 2021-2022 | |
| Althera Pharmaceuticals LLC | $28.46 | 2021-2022 | |
| Collegium Pharmaceutical, INC. | $26.87 | 2022 | |
| Exact Sciences Corporation | $26.37 | 2023 | Cologuard Collection Kit |
| Idorsia Pharmaceuticals US INC | $25.74 | 2022 | |
| Philips North America LLC | $24.74 | 2021-2023 | |
| Baxter Healthcare | $20.26 | 2025 | Hillrom - Monarch Airway Clearance System |
| Dexcom, INC. | $15.13 | 2024 | Dexcom G6 Transmitter |
| Vivus LLC | $15.00 | 2021 | |
| Eisai INC. | $15.00 | 2021 | |
| Biohaven Pharmaceutical Holding Company LTD. | $14.91 | 2022 | |
| Shionogi INC | $14.32 | 2019 | |
| Arbor Pharmaceuticals, INC. | $12.26 | 2019 | |
| Medtronic, INC. | $11.40 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ellen Vitievsky listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.